Breaking News Instant updates and real-time market news.

SWN

Southwestern Energy

$10.77

0.39 (3.76%)

, CNC

Centene

$58.80

2.08 (3.67%)

09:55
12/21/16
12/21
09:55
12/21/16
09:55

Early notable gainers among liquid option names on December 21st

Notable gainers among liquid option names this morning include Southwestern Energy (SWN) $10.80 +0.42, Centene (CNC) $58.46 +1.73, Owens-Illinois (OI) $18.28 +0.50, Monster Beverage (MNST) $44.74 +1.20, and EQT Corporation (EQT) $67.29 +1.64.

SWN

Southwestern Energy

$10.77

0.39 (3.76%)

CNC

Centene

$58.80

2.08 (3.67%)

OI

Owens-Illinois

$18.10

0.33 (1.86%)

MNST

Monster Beverage

$43.54

-0.33 (-0.75%)

EQT

EQT Corporation

$67.07

1.42 (2.16%)

  • 02

    Feb

  • 07

    Feb

SWN Southwestern Energy
$10.77

0.39 (3.76%)

11/28/16
BMOC
11/28/16
UPGRADE
BMOC
Outperform
Southwestern Energy upgraded to Outperform from Market Perform at BMO Capital
12/02/16
TUDR
12/02/16
DOWNGRADE
TUDR
Hold
Southwestern Energy downgraded to Hold from Buy at Tudor Pickering
11/28/16
BMOC
11/28/16
UPGRADE
BMOC
Outperform
Southwestern Energy upgraded on valuation, potential gas upturn at BMO Capital
As noted earlier, BMO Capital upgraded Southwestern Energy to Outperform from Market Perform. Analyst Dan McSpirit upgraded the stock based on valuation and his belief that the natural gas supply/demand balance could improve. Target $18.
11/10/16
KLRG
11/10/16
UPGRADE
Target $14
KLRG
Buy
Southwestern Energy upgraded to Buy from Accumulate at KLR Group
KLR Group analyst John Gerdes upgraded Southwestern Energy to Buy citing valuation with the shares down over 30% in the past month. The analyst keeps a $14 price target for the shares.
CNC Centene
$58.80

2.08 (3.67%)

12/13/16
GSCO
12/13/16
UPGRADE
Target $63
GSCO
Neutral
Centene upgraded to Neutral from Sell at Goldman
Goldman analyst Matthew Borsch upgraded Centene to Neutral saying valuation reflects downside risk and maintained its $63 price target.
12/16/16
OPCO
12/16/16
NO CHANGE
Target $89
OPCO
Outperform
Oppenheimer remains a buyer of Centene on any volatility
Oppenheimer analyst Michael Wiederhorn notes that Centene's guidance was likely slightly lower than expected, but says it is explained by the 20c/share impact of the Exchange business. Nonetheless, the analyst continues to favor Centene due to its growth outlook and attractive valuation, and would continue to be a buyer on any volatility. He reiterates an Outperform rating and $89 price target on the shares.
12/19/16
WELS
12/19/16
NO CHANGE
WELS
Centene weakness creates buying opportunity, says Wells Fargo
After attending Centene's Investor Day, Wells Fargo notes that the company's guidance was lower than expected but incorporated a conservative view of its public exchange business. However, Wells continues to believe that the company is well-positioned due to "the continued shift towards managed care in the high acuity Medicaid population, (its) track record in winning new government businesses, and a new growth platform in Medicare following its Health Net acquisition." The firm keeps an Outperform rating on Centene.
12/21/16
JPMS
12/21/16
INITIATION
Target $75
JPMS
Overweight
Centene initiated with an Overweight at JPMorgan
JPMorgan analyst Gary Taylor started Centene with an Overweight rating and $75 price target. The analyst also added the shares to his firm's Analyst Focus List. The company has an "impressive track record" of operating performance and state contract wins, Taylor tells investors in a research note.
OI Owens-Illinois
$18.10

0.33 (1.86%)

04/06/16
04/06/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. CRH (CRH) upgraded to Overweight at JPMorgan by analyst Elodie Rall, who views the valuation as attractive and sees limited risk to estimates. 2. Ironwood (IRWD) upgraded to Outperform at Cowen citing the company's pipeline and ex-U.S. royalties as well as U.S. co-marketing agreements leaving room for growth. 3. Owens-Illinois (OI) upgraded to Buy at Citi with analyst Anthony Pettinari citing valuation and a low bar set by management for 2016. 4. Pennsylvania REIT (PEI) upgraded to Outperform at Boenning & Scattergood by analyst Floris van Dijkum, who believes Pennsylvania REIT's discounted valuation is unwarranted given significant acceleration in 2018 NOI growth. van Dijkum expects the company to continue to reduce leverage by selling other non-core assets and make development progress on the Fashion Outlets of Philadelphia. 5. Cisco (CSCO) upgraded to Neutral at JPMorgan with analyst Rod Hall saying the company's 3.8% dividend yield is "compelling in the midst of current market volatility." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/12/16
GSCO
05/12/16
INITIATION
Target $18
GSCO
Sell
Owens-Illinois initiated with a Sell at Goldman
Goldman analyst Brian Maguire initiated Owens-Illinois with a Sell and $18 price target.
09/29/16
RBCM
09/29/16
INITIATION
RBCM
Sector Perform
Owens-Illinois initiated with a Sector Perform at RBC Capital
05/12/16
05/12/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amarin (AMRN) assumed with a Buy at Jefferies by analyst Hugo Ong, who said off-label Vascepa promotion in mixed dyslipidemia may be beginning to bear fruit. 2. Theravance Biopharma (TBPH) initiated with an Outperform at Leerink with analyst Paul Matteis saying he sees a favorable risk/reward ahead of a string of clinical/commercial catalysts over the next year. 3. Graphic Packaging (GPK) initiated with a Conviction Buy at Goldman. 4. Owens-Illinois (OI) initiated with a Sell at Goldman. 5. Sonoco Products (SON) initiated with a Neutral at Goldman. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MNST Monster Beverage
$43.54

-0.33 (-0.75%)

11/04/16
RBCM
11/04/16
NO CHANGE
RBCM
Monster Beverage 'bull case still intact,' says RBC Capital
After Monster (MNST) reported weaker than expected results, RBC Capital analyst Nik Modi blames the miss partially on the company's transition to Coca-Cola's (KO) system. The analyst says that the company was off to a strong start in October, and he continues to believe that its growth will be boosted by innovation. He keeps an Outperform rating on the shares.
11/04/16
STFL
11/04/16
NO CHANGE
STFL
Monster Beverage results 'better than feared,' says Stifel
Although Monster's Q3 results came in below expectations, they were "better than feared," according to Stifel analyst Mark Astrachan. The analyst blames the miss partly on higher expenses and shipment timing. He notes that the company's gross sales accelerated meaningfully in October versus Q3, and he thinks that its U.S. market remains strong. The analyst trimmed his price target on the name to $178 from $185 and keeps a Buy rating.
12/21/16
JEFF
12/21/16
NO CHANGE
Target $63
JEFF
Buy
Newell Brands added to Franchise Picks List at Jefferies
Jefferies analyst Kevin Grundy added Newell Brands (NWL) to his firm's Franchise Picks List while raising his price target for the shares to $63 from $61. Investors have "multiple ways to win" as the company's "myriad" of "value triggers" are being underappreciated, Grundy tells investors in a research note. He keeps a Buy rating on Newell. The analyst this morning also upgraded Monster Beverage (MNST) to Buy from Hold.
12/21/16
JEFF
12/21/16
UPGRADE
Target $58
JEFF
Buy
Monster Beverage upgraded to Buy from Hold at Jefferies
Jefferies analyst Kevin Grundy upgraded Monster Beverage (MNST) to Buy and calls the stock his top large cap growth pick in Consumer Products. The analyst highlights Monster's accelerating sales growth in the U.S. and international market share gains. He views the current valuation as attractive and sees strategic optionality should Coca-Cola (KO) acquire the remaining 82% of the shares it does not own. Grundy raised his price target for Monster Beverage shares to $58 from $53.
EQT EQT Corporation
$67.07

1.42 (2.16%)

12/09/16
GHSC
12/09/16
DOWNGRADE
GHSC
Neutral
EQT Corporation downgraded to Neutral from Accumulate at Seaport Global
10/28/16
SBSH
10/28/16
UPGRADE
Target $80
SBSH
Buy
EQT Corporation upgraded to Buy from Neutral at Citi
Citi analyst Vikram Bagri upgraded EQT Corporation to Buy citing improving fundamentals and an attractive valuation following the company's Q3 results. He raised his price target for the shares to $80 from $75.
11/17/16
DRXL
11/17/16
INITIATION
Target $86
DRXL
Buy
EQT Corporation initiated with a Buy at Drexel Hamilton
Drexel Hamilton analyst John Ragozzino initiated EQT Midstream with a Buy and an $86 price target.
10/24/16
FBCO
10/24/16
INITIATION
Target $86
FBCO
Outperform
EQT Corporation initiated with an Outperform at Credit Suisse
Credit Suisse analyst Mark Lear initiated EQT Corporation with an Outperform and an $86 price target saying it is positioned in the heart of the Marcellus shale with potential upside from further delineation in the Utica Shale, a recovery in gas prices and the ability to extend laterals in the Marcellus.

TODAY'S FREE FLY STORIES

TSLA

Tesla

$315.05

2.55 (0.82%)

10:21
11/18/17
11/18
10:21
11/18/17
10:21
Periodicals
Tesla new super car to cost $200,000, Recode says »

Alongside its new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 16

    Jan

GT

Goodyear Tire

$29.94

0.63 (2.15%)

10:17
11/18/17
11/18
10:17
11/18/17
10:17
Hot Stocks
Goodyear Tire, NASCAR extend relationship »

NASCAR and Goodyear Tire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Jan

  • 16

    Jan

HMC

Honda

$32.62

0.02 (0.06%)

10:05
11/18/17
11/18
10:05
11/18/17
10:05
Periodicals
Honda recalls 900,000 minivans on tip forward seats, Reuters says »

Honda Motor is recalling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$88.43

-0.82 (-0.92%)

09:48
11/18/17
11/18
09:48
11/18/17
09:48
Periodicals
Activist investors Nelson Peltz still in P&G picture, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHGE

Baker Hughes

$30.91

0.76 (2.52%)

, GE

General Electric

$18.21

-0.04 (-0.22%)

09:39
11/18/17
11/18
09:39
11/18/17
09:39
Periodicals
Buy Baker Hughes, Barron's says »

While it is "not…

BHGE

Baker Hughes

$30.91

0.76 (2.52%)

GE

General Electric

$18.21

-0.04 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

CSCO

Cisco

$35.90

0.02 (0.06%)

09:19
11/18/17
11/18
09:19
11/18/17
09:19
Periodicals
More needed for Cisco to have 'groove back,' Barron's says »

While the Nasdaq…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 11

    Dec

  • 17

    Jan

  • 17

    Jan

IBM

IBM

$148.97

-0.15 (-0.10%)

09:10
11/18/17
11/18
09:10
11/18/17
09:10
Periodicals
IBM could be next to fetch higher valuation, Barron's says »

Investors are warming to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

GE

General Electric

$18.21

-0.04 (-0.22%)

09:05
11/18/17
11/18
09:05
11/18/17
09:05
Periodicals
Option play offer some help given GE dividend, depressed stock, Barron's says »

While wagering against…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$18.21

-0.04 (-0.22%)

09:00
11/18/17
11/18
09:00
11/18/17
09:00
Periodicals
Risk remains after GE dividend cut, Barron's says »

While buying General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$88.72

0.71 (0.81%)

, T

AT&T

$34.51

-0.01 (-0.03%)

08:21
11/18/17
11/18
08:21
11/18/17
08:21
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

TWX

Time Warner

$88.72

0.71 (0.81%)

T

AT&T

$34.51

-0.01 (-0.03%)

NYT

New York Times

$17.65

0.05 (0.28%)

TEX

Terex

$44.82

0.8 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

TPIC

TPI Composites

$19.06

-0.97 (-4.84%)

07:25
11/18/17
11/18
07:25
11/18/17
07:25
Conference/Events
TPI Composites to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SYNA

Synaptics

$38.21

0.57 (1.51%)

04:55
11/18/17
11/18
04:55
11/18/17
04:55
Conference/Events
Synaptics management to meet with KeyBanc »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

, BRCD

Brocade

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

BRCD

Brocade

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 06

    Dec

WGL

WGL Holdings

$84.32

-0.14 (-0.17%)

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Earnings
WGL Holdings reports Q4 adjusted EPS (17c), consensus (19c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

, LMOS

Lumos Networks

17:58
11/17/17
11/17
17:58
11/17/17
17:58
Hot Stocks
Tactile Systems to replace Lumos Networks in S&P 600 at open on 11/22 »

EQT Infrastructure…

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

, MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

17:56
11/17/17
11/17
17:56
11/17/17
17:56
Hot Stocks
Breaking Hot Stocks news story on Invesco Mortgage, MKS Instruments »

Invesco Mortgage to…

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

, BRCD

Brocade

17:55
11/17/17
11/17
17:55
11/17/17
17:55
Hot Stocks
MKS Instruments to replace Brocade in S&P 400 at open on 11/22 »

S&P 500 constituent…

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

BRCD

Brocade

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

UQM

UQM Technologies

$1.18

0.015 (1.29%)

17:24
11/17/17
11/17
17:24
11/17/17
17:24
Syndicate
Breaking Syndicate news story on UQM Technologies »

UQM Technologies files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$238.02

-1.35 (-0.56%)

17:23
11/17/17
11/17
17:23
11/17/17
17:23
Periodicals
Goldman Sachs has $510M lawsuit dismissed, Reuters reports »

A $510M lawsuit that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VICL

Vical

$1.94

-0.02 (-1.02%)

17:18
11/17/17
11/17
17:18
11/17/17
17:18
Hot Stocks
Breaking Hot Stocks news story on Vical »

Biotechnology Value Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:18
11/17/17
11/17
17:18
11/17/17
17:18
Hot Stocks
Ligand director sells 5,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:17
11/17/17
11/17
17:17
11/17/17
17:17
Hot Stocks
Ligand CFO sells 6,559 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:17
11/17/17
11/17
17:17
11/17/17
17:17
Hot Stocks
Ligand CEO sells 5,269 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBI

MBIA

$9.01

0.13 (1.46%)

17:15
11/17/17
11/17
17:15
11/17/17
17:15
Hot Stocks
Breaking Hot Stocks news story on MBIA »

Fine Capital Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBCN

Rubicon

$8.07

0.1218 (1.53%)

17:03
11/17/17
11/17
17:03
11/17/17
17:03
Hot Stocks
Breaking Hot Stocks news story on Rubicon »

Bandera Partners reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.